Korean Med Sci 1987 Sep;2(3):157-165
A clinical study of topical mucopolysaccharides & polydeoxyribonucleoprotein (Foltene) therapy in alopecia.
Lee KS, Myung KB, Kook HI
Department of Dermatology, College of Medicine, Ewha Womans University.
We performed clinical trials to evaluate the therapeutic effects of Foltene in patients of the several types of hair fallings. Thirtypatients with male pattern baldness, alopecia areata and seborrheic alopecia were included in this study. Foltene was appliedevery other day for 40 days, and followed by maintenance therapy of twice application a week. The duration of whole therapywas 6 months. We conclude that Foltene is an effective and agent for male pattern baldness, alopecia areata and seborrheicalopecia from the following results. Ten patients with male pattern baldness was treated with Foltene for 6 months. Foltene hadtherapeutic effects of 50% in hair regrowth, 70% in decreased hair falls, 30% in decreased dandruff, 50% in decreasedseborrhea. Thirteen patients with alopecia areata was treated with Foltene for 6 months. Foltene had therapeutic effects of61.6% in hair regrowth, 53.9% in decreased in hair falls, 53.9% in decreased dandruff, 77.0% in decreased seborrhea. Sevenpatients with seborrheic alopecia was treatment with Foltene for 6 months. Foltene had therapeutic effects of 85.8% in hairregrowth, 57.2% in decreased hair falls, 42.9% in decreased dandruff, 85.8% in decreased seborrhea. The degree oftherapeutic success was related to the duration of therapy. The side effects were as followed: itching sensation developed in 2patients (6.7%); tingling sensation in 3 patients (10.0%); burning sensation in 1 patient (3.3%); erythema in 3 patients (10.0%).
PMID: 2978541, UI: 90027321
Torna agli shampoo